Samsara BioCapital as of Sept. 30, 2024
Portfolio Holdings for Samsara BioCapital
Samsara BioCapital holds 42 positions in its portfolio as reported in the September 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Cargo Therapeutics (CRGX) | 15.7 | $82M | 4.4M | 18.45 | |
| Mineralys Therapeutics (MLYS) | 11.8 | $62M | 5.1M | 12.11 | |
| Scholar Rock Hldg Corp (SRRK) | 10.5 | $54M | 6.8M | 8.01 | |
| Neurogene (NGNE) | 10.2 | $53M | 1.3M | 41.96 | |
| Alumis Common Stock (ALMS) | 6.7 | $35M | 3.3M | 10.68 | |
| Arcellx Common Stock (ACLX) | 5.7 | $30M | 354k | 83.51 | |
| Lenz Therapeutics (LENZ) | 5.5 | $29M | 1.2M | 23.74 | |
| Nkarta (NKTX) | 3.3 | $17M | 3.8M | 4.52 | |
| Eliem Therapeutics (ELYM) | 2.6 | $13M | 2.6M | 5.09 | |
| Avadel Pharmaceuticals Com Shs (AVDL) | 2.4 | $13M | 968k | 13.12 | |
| Zymeworks Del (ZYME) | 2.4 | $13M | 1.0M | 12.55 | |
| Acelyrin (SLRN) | 2.4 | $12M | 2.5M | 4.93 | |
| Contineum Therapeutics Cl A (CTNM) | 2.2 | $11M | 589k | 19.14 | |
| Jasper Therapeutics Com New (JSPR) | 2.1 | $11M | 585k | 18.81 | |
| Abivax Sa Sponsored Ads (ABVX) | 1.9 | $9.8M | 850k | 11.52 | |
| Rhythm Pharmaceuticals (RYTM) | 1.7 | $9.0M | 173k | 52.39 | |
| Inozyme Pharma (INZY) | 1.6 | $8.2M | 1.6M | 5.23 | |
| Sutro Biopharma (STRO) | 1.5 | $7.6M | 2.2M | 3.46 | |
| Leap Therapeutics Com New (LPTX) | 1.2 | $6.3M | 2.4M | 2.57 | |
| Gossamer Bio (GOSS) | 1.2 | $6.0M | 6.1M | 0.99 | |
| Verona Pharma Sponsored Ads (VRNA) | 1.1 | $5.6M | 195k | 28.77 | |
| Tango Therapeutics (TNGX) | 0.9 | $4.9M | 630k | 7.70 | |
| Artiva Biotherapeutics Common Stock | 0.9 | $4.5M | 292k | 15.45 | |
| Syros Pharmaceuticals Com New (SYRS) | 0.7 | $3.8M | 1.8M | 2.15 | |
| Io Biotech (IOBT) | 0.7 | $3.8M | 3.6M | 1.05 | |
| Vtv Therapeutics Cl A New (VTVT) | 0.5 | $2.8M | 207k | 13.56 | |
| Immatics SHS (IMTX) | 0.4 | $2.3M | 198k | 11.41 | |
| Prime Medicine (PRME) | 0.4 | $2.1M | 540k | 3.87 | |
| Day One Biopharmaceuticals I (DAWN) | 0.4 | $2.1M | 147k | 13.93 | |
| Terns Pharmaceuticals (TERN) | 0.3 | $1.7M | 202k | 8.34 | |
| Hillevax (HLVX) | 0.3 | $1.4M | 799k | 1.76 | |
| Janux Therapeutics (JANX) | 0.2 | $1.0M | 23k | 45.43 | |
| Bicara Therapeutics Common Stock | 0.2 | $892k | 35k | 25.47 | |
| Aclaris Therapeutics (ACRS) | 0.2 | $801k | 696k | 1.15 | |
| Lyra Therapeutics (LYRA) | 0.1 | $715k | 2.8M | 0.26 | |
| Bolt Biotherapeutics (BOLT) | 0.1 | $680k | 1.0M | 0.65 | |
| Viracta Therapeutics (VIRX) | 0.0 | $160k | 690k | 0.23 | |
| Allakos (ALLK) | 0.0 | $112k | 172k | 0.65 | |
| Kronos Bio (KRON) | 0.0 | $78k | 78k | 1.00 | |
| Allovir (ALVR) | 0.0 | $67k | 82k | 0.81 | |
| Nuvation Bio *w Exp 07/07/202 (NUVB.WS) | 0.0 | $13k | 133k | 0.10 | |
| Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $1.0k | 100k | 0.01 |
